Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Burkitt Lymphoma × pembrolizumab × Clear all

Sponsor

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 23 Carcinoma, Non-Small-Cell Lung 6 Melanoma 4 Uterine Cervical Neoplasms 3 Esophageal Neoplasms 3 Endometrial Neoplasms 3 Colorectal Neoplasms 3 Carcinoma, Renal Cell 3 Urothelial Cancer 2 Triple Negative Breast Neoplasms 2 Neoplasms 2 Mesothelioma 2 Head and Neck Neoplasms 2 Cholangiocarcinoma 2 Bile Duct Neoplasms 2 Vulvar Neoplasms 1 Uveal Melanoma 1 Urologic Neoplasms 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Salivary Gland Neoplasms 1 Parotid Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Neoplasm Metastasis 1

Interventions

Vincristine 3 Methotrexate 3 Cytarabine 3 Cyclophosphamide 3 pegaspargase 2 merphos 2 blinatumomab 2 X-Rays 2 Spinal Puncture 2 Specimen Handling 2 Rituximab 2 Leucovorin 2 Biopsy 2 tisagenlecleucel 1 prednylidene 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 deltacortene 1 calaspargase pegol 1 azathiopurine 1 auricularum 1 asparaginase erwinia chrysanthemi recombinant 1 Stem Cell Transplantation 1 Prednisone 1 Phantoms, Imaging 1 N,N-dicyclohexyl-isoborneol-10-sulfonamide 1 Mercaptopurine 1 Inotuzumab Ozogamicin 1 Etoposide 1 Doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡